Document Detail

Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
MedLine Citation:
PMID:  15316109     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To describe a case of oral valproic acid-induced hyperammonemia and thrombocytopenia in an elderly patient. CASE SUMMARY: A 76-year-old white woman presented to the emergency department with generalized weakness, confusion, nausea, and vomiting. She was taking sodium divalproex 750 mg 3 times daily, with valproic acid concentration 144 mg/L. She was admitted to the medical ward. The dose of sodium divalproex was decreased and discontinued. During her hospital stay, the woman's ammonia level rose to 211 microg/dL despite a normal valproic acid concentration. She was confused, somnolent, and had decreased mobility. Her platelet count decreased from 133 to 86 x 10(3)/mm(3). Gabapentin was prescribed for seizure control. The patient's mental status, ammonia level, and platelet count returned to baseline following discontinuation of valproic acid. DISCUSSION: It has been reported that valproic acid can interfere with the enzyme carbamoylphosphate synthetase, which is responsible for incorporating ammonia into the urea cycle. It has also been reported that valproic acid can increase the transport of glutamine across the mitochondrial membrane in the kidney, thereby increasing the production of ammonia. The etiology of valproic acid-induced thrombocytopenia has not been elucidated. Using the Naranjo probability scale, a probable relationship between hyperammonemia and valproic acid and a possible relationship between thrombocytopenia and valproic acid were determined. CONCLUSIONS: Valproic acid can be associated with hyperammonemia and thrombocytopenia. Clinicians should be aware of changes in patients' cognitive and functional capacity, especially elderly patients on sodium divalproex.
Louise Mallet; Steve Babin; José A Morais
Related Documents :
23140499 - Diversity of phenolic profiles in the fruit skin of prunus domestica plums and related ...
22807469 - Arsenic contamination of coarse-grained and nanostructured nitinol surfaces induced by ...
15032379 - Effects of valproic acid on longitudinal bone growth.
12597989 - Inactivation of creatine kinase during the interaction of mefenamic acid with horseradi...
24114299 - Evaluation of lipoic acid topical application on rats skin wound healing.
122159 - Gas chromatographic method for the determination of valproic acid in human plasma.
12065199 - The antinociceptive effect of intrathecal kynurenic acid and its interaction with endom...
6692399 - Sialyltransferase of the 13762 rat mammary ascites tumor cells.
19467059 - Esters of para-aminobenzoic acid in cosmetics. identification and dosage within sun-cre...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2004-08-17
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  38     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-17     Completed Date:  2004-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1643-7     Citation Subset:  IM    
Faculty of Pharmacy, University of in Geriatrics, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ammonia / blood
Anticonvulsants / adverse effects*
Hyperammonemia / chemically induced*
Platelet Count
Thrombocytopenia / chemically induced
Valproic Acid / adverse effects*,  blood
Reg. No./Substance:
0/Anticonvulsants; 7664-41-7/Ammonia; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Respiratory stimulant use in chronic obstructive pulmonary disease.
Next Document:  DNA replication licensing affects cell proliferation or endoreplication in a cell type-specific mann...